Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on March 9, 2026

Mar. 9, 2026

SPARC AI Ready to Deploy Overwatch to Ukraine

Indeterminate GlobeNewswire

Mar. 9, 2026

Korro Announces Oversubscribed $85 Million Private Placement

Indeterminate GlobeNewswire

Mar. 9, 2026

Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit

Indeterminate GlobeNewswire

Mar. 9, 2026

Movellus Advanced Clocking IP Selected for QuickLogic’s Strategic Radiation Hardened FPGA Program

Indeterminate GlobeNewswire

Mar. 9, 2026

Dianthus Therapeutics Highlights Recent Business Achievements, Including GO Decision for Phase 3 CAPTIVATE CIDP Trial, and Reports Q4 and FY 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 9, 2026

Ubitium tapes out universal processor to end embedded computing complexity crisis

Indeterminate GlobeNewswire

Mar. 9, 2026

Skyryse Announces Universal, Emergency Autoland Capability Coming to SkyOS™, Bringing Automated Safe Landings to Both Helicopters and Airplanes

Indeterminate GlobeNewswire

Mar. 9, 2026

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing

Indeterminate GlobeNewswire

Mar. 9, 2026

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Mar. 9, 2026

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

Indeterminate GlobeNewswire

Mar. 9, 2026

Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 9, 2026

DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk

Indeterminate GlobeNewswire

Mar. 9, 2026

iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss

Indeterminate GlobeNewswire

Mar. 9, 2026

Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Indeterminate GlobeNewswire

Mar. 9, 2026

Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China

Indeterminate GlobeNewswire

Mar. 9, 2026

Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)

Indeterminate GlobeNewswire

Mar. 9, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Indeterminate GlobeNewswire

Mar. 9, 2026

Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 9, 2026

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

Indeterminate GlobeNewswire

Mar. 9, 2026

NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

Indeterminate GlobeNewswire